Eveo: announcement and planned order timeline
Summary
Manufacturer announcement with a planned order timeline; current availability remains unconfirmed.
Source Date
March 16, 2026
Source checked
October 4, 2026
Event Type
announcement
Event Date
March 16, 2026
Geography
Availability jurisdiction not established
Commercial Regulatory Status
announced; September 2026 order-taking was planned, but current opening of orders is not confirmed from a newer primary source as of 4 October 2026
Related CFCM Topics
/flow-cytometry-cell-therapy-release /resources
Category
Technology
Primary source
Read the source →Facts supported by cited sources
Sartorius issued an Eveo platform announcement on 16 March 2026.
The announcement planned orders for September 2026 and initial deliveries in 2027.
Claims Requiring Caution
The announcement does not confirm that orders have now opened.
Output and cost improvements are manufacturer claims; clinical release-assay validation and regulatory authorisation are not established by this source.
Why It Matters
CFCM analysis: monitor implications for flow cytometry in cell-therapy QC; assess each assay's intended use and validation independently.
An announcement is not proof of availability or authorisation. Interpret status within the stated jurisdiction and evidence boundary.
Editor and independence disclosure →